Healthpeak Properties (NYSE:DOC) Price Target Cut to $17.50 by Analysts at Citigroup

Healthpeak Properties (NYSE:DOC) had its price target decreased by research analysts at Citigroup from $18.00 to $17.50 in a report issued on Wednesday,Benzinga reports. The firm currently has a “neutral” rating on the real estate investment trust’s stock. Citigroup’s price objective would indicate a potential upside of 6.66% from the company’s previous close.

Other analysts also recently issued reports about the company. Wells Fargo & Company reaffirmed a “positive” rating on shares of Healthpeak Properties in a report on Tuesday, February 3rd. Jefferies Financial Group downgraded Healthpeak Properties from a “buy” rating to a “hold” rating and dropped their price objective for the company from $21.00 to $17.00 in a report on Monday, December 15th. Wall Street Zen lowered Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Saturday. Argus downgraded Healthpeak Properties from a “buy” rating to a “hold” rating in a report on Thursday, February 5th. Finally, The Goldman Sachs Group started coverage on shares of Healthpeak Properties in a research note on Friday, January 9th. They issued a “neutral” rating and a $17.00 price target on the stock. Six analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat.com, Healthpeak Properties presently has a consensus rating of “Hold” and a consensus target price of $19.27.

Healthpeak Properties Stock Down 0.1%

Healthpeak Properties stock traded down $0.02 during trading on Wednesday, reaching $16.41. The stock had a trading volume of 11,527,826 shares, compared to its average volume of 9,354,226. The company has a quick ratio of 2.82, a current ratio of 2.82 and a debt-to-equity ratio of 1.21. Healthpeak Properties has a 52-week low of $15.71 and a 52-week high of $20.10. The stock has a market cap of $11.41 billion, a PE ratio of 164.09, a P/E/G ratio of 8.86 and a beta of 1.11. The business has a 50 day moving average price of $17.16 and a 200 day moving average price of $17.48.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings data on Monday, February 2nd. The real estate investment trust reported $0.47 EPS for the quarter, beating analysts’ consensus estimates of $0.45 by $0.02. The company had revenue of $719.40 million for the quarter, compared to the consensus estimate of $685.14 million. Healthpeak Properties had a net margin of 2.52% and a return on equity of 0.84%. The company’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. On average, analysts predict that Healthpeak Properties will post 1.86 EPS for the current year.

Institutional Investors Weigh In On Healthpeak Properties

A number of institutional investors and hedge funds have recently added to or reduced their stakes in DOC. State Street Corp increased its stake in Healthpeak Properties by 1.8% in the 3rd quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust’s stock valued at $947,889,000 after buying an additional 895,460 shares during the period. JPMorgan Chase & Co. boosted its holdings in shares of Healthpeak Properties by 8.6% in the fourth quarter. JPMorgan Chase & Co. now owns 30,674,812 shares of the real estate investment trust’s stock valued at $493,251,000 after acquiring an additional 2,438,278 shares in the last quarter. Fuller & Thaler Asset Management Inc. boosted its holdings in shares of Healthpeak Properties by 19.2% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock valued at $476,744,000 after acquiring an additional 4,776,056 shares in the last quarter. Geode Capital Management LLC increased its stake in shares of Healthpeak Properties by 0.6% during the fourth quarter. Geode Capital Management LLC now owns 19,534,041 shares of the real estate investment trust’s stock worth $312,959,000 after acquiring an additional 123,274 shares during the period. Finally, Invesco Ltd. increased its stake in shares of Healthpeak Properties by 9.9% during the fourth quarter. Invesco Ltd. now owns 18,298,776 shares of the real estate investment trust’s stock worth $294,244,000 after acquiring an additional 1,648,012 shares during the period. Hedge funds and other institutional investors own 93.57% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.